Search - tctmd.com

Displaying 141 - 160 of 256

Sort: Relevancy | Date

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Michael O'Riordan

July 30, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Conference News SCCT 2019

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Yael L. Maxwell

July 15, 2019

News Daily News

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Yael L. Maxwell

July 04, 2019

News Daily News

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

L.A. McKeown

May 13, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Daily News

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Michael O'Riordan

April 24, 2019

News Daily News

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Michael O'Riordan

April 18, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Caitlin E. Cox

February 27, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Daily News

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

Caitlin E. Cox

December 04, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Caitlin E. Cox

October 31, 2018

Advertisement

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content